Sintx Technologies (SINT) Gross Profit Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.54% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 9.03% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.49% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.46% |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | -30.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.07% |
| Dec 31, 2025 | -36.52% |
| Sep 30, 2025 | -34.89% |
| Jun 30, 2025 | -31.06% |
| Mar 31, 2025 | 35.91% |
| Dec 31, 2024 | 113.27% |
| Sep 30, 2024 | 129.07% |
| Jun 30, 2024 | 183.06% |
| Mar 31, 2024 | 126.37% |
| Dec 31, 2023 | 170.85% |
| Sep 30, 2023 | 250.76% |
| Jun 30, 2023 | 114.39% |
| Mar 31, 2023 | 117.35% |
| Dec 31, 2022 | 124.45% |
| Sep 30, 2022 | 148.35% |
| Jun 30, 2022 | 72.33% |
| Mar 31, 2022 | 39.63% |
| Jun 30, 2021 | -73.58% |
| Mar 31, 2021 | -71.71% |
| Dec 31, 2020 | 26.42% |
| Sep 30, 2020 | -79.67% |
| Jun 30, 2020 | -74.55% |
| Mar 31, 2020 | -72.48% |
| Dec 31, 2019 | -70.57% |
| Sep 30, 2019 | -79.66% |
| Jun 30, 2019 | -77.55% |
| Mar 31, 2019 | -82.36% |
| Jun 30, 2018 | -23.70% |
| Mar 31, 2018 | -18.14% |
| Dec 31, 2017 | -35.05% |
| Sep 30, 2017 | -27.48% |
| Jun 30, 2017 | -16.26% |
| Mar 31, 2017 | -21.90% |
| Dec 31, 2016 | 34.82% |
| Sep 30, 2016 | -9.80% |
| Jun 30, 2016 | -13.99% |
| Mar 31, 2016 | -5.09% |